Evidence map›Paper›PMID 37303066›Full record

ArticleTropical medicine and health2023

Medicinal plants used for treatment of malaria by indigenous communities of Tororo District, Eastern Uganda.

John R S Tabuti, Samuel Baker Obakiro, Alice Nabatanzi, Godwin Anywar, Cissy Nambejja, Michael R Mutyaba, Timothy Omara, Paul Waako

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Inhibitory Effects ofACS omega · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Potentials ofInfection and drug resistance · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

John R S TabutiDepartment of Environmental Management, Makerere University, P.O. Box 7062, Kampala, Uganda.ORCID http://orcid.org/0000-0001-9024-9181
Samuel Baker ObakiroDepartment of Pharmacology and Therapeutics, Faculty of Health Sciences, Busitema University, P.O. Box 1460, Mbale, Uganda. sobakiro@gmail.com.ORCID http://orcid.org/0000-0001-9258-2519
Alice NabatanziDepartment of Plant Sciences, Microbiology & Biotechnology, College of Natural Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.ORCID http://orcid.org/0000-0002-5675-9345
Godwin AnywarDepartment of Plant Sciences, Microbiology & Biotechnology, College of Natural Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.ORCID http://orcid.org/0000-0003-0926-1832
Cissy NambejjaNatural Chemotherapeutics Research Institute (NCRI), Ministry of Health, P.O. Box 4864, Kampala, Uganda.
Michael R MutyabaNational Drug Authority, Ministry of Health, P.O. Box 23096, Kampala, Uganda.
Timothy OmaraInstitute of Chemistry of Renewable Resources, Department of Chemistry, University of Natural Resources and Life Sciences, Vienna (BOKU), The Tulln University and Research Center (UFT), Konrad-Lorenz-Straße 24, 3430, Tulln an der Donau, Austria.ORCID http://orcid.org/0000-0002-0175-1055
Paul WaakoDepartment of Pharmacology and Therapeutics, Faculty of Health Sciences, Busitema University, P.O. Box 1460, Mbale, Uganda.ORCID http://orcid.org/0000-0001-8964-8775
Makerere University · UGBusitema University · UGMinistry of Health · UGBOKU University · AT

Funding

Makerere University Research and Innovations Fund RIF 1/CAES/025
6 · The paper itself

Abstract

backgroundMalaria remains the leading cause of death in sub-Saharan Africa. Although recent developments such as malaria vaccine trials inspire optimism, the search for novel antimalarial drugs is urgently needed to control the mounting resistance of Plasmodium species to the available therapies. The present study was conducted to document ethnobotanical knowledge on the plants used to treat symptoms of malaria in Tororo district, a malaria-endemic region of Eastern Uganda.

methodsAn ethnobotanical study was carried out between February 2020 and September 2020 in 12 randomly selected villages of Tororo district. In total, 151 respondents (21 herbalists and 130 non-herbalists) were selected using multistage random sampling method. Their awareness of malaria, treatment-seeking behaviour and herbal treatment practices were obtained using semi-structured questionnaires and focus group discussions. Data were analysed using descriptive statistics, paired comparison, preference ranking and informant consensus factor.

resultsA total of 45 plant species belonging to 26 families and 44 genera were used in the preparation of herbal medicines for management of malaria and its symptoms. The most frequently mentioned plant species were Vernonia amygdalina, Chamaecrista nigricans, Aloe nobilis, Warburgia ugandensis, Abrus precatorius, Kedrostis foetidissima, Senna occidentalis, Azadirachta indica and Mangifera indica. Leaves (67.3%) were the most used plant part while maceration (56%) was the major method of herbal remedy preparation. Oral route was the predominant mode of administration with inconsistencies in the posology prescribed.

conclusionThis study showed that the identified medicinal plants in Tororo district, Uganda, are potential sources of new antimalarial drugs. This provides a basis for investigating the antimalarial efficacy, phytochemistry and toxicity of the unstudied species with high percentage use values to validate their use in the management of malaria.

Indexed as

Antimalarial resistanceEthnobotanyIndigenous knowledgeMalariaMedicinal plantsTraditional medicine

Identifiers

PMID37303066
PMCPMC10258082
OpenAlexW4380272288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.